Spots Global Cancer Trial Database for Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Official Title: A Phase Ib/II Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Study ID: NCT02423954
Study Description
Brief Summary: Determine Phase 2 dose of study drug
Detailed Description: Determine the recommended phase 2 dose (RP2D) of chemotherapy in combination with nivolumab in subjects with advanced cancer.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer Treatment Center of America @ Western Regional Medical Center, Goodyear, Arizona, United States
Contact Details
Name: Jordan Waypa, MSN, FNP
Affiliation: Western Regional Medical Center
Role: STUDY_DIRECTOR
Name: Cynthia Lynch, MD
Affiliation: Western Regional Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
